A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is
Symbiotic Treatment Improve IBS Symptoms and Quality of Life: Placebo-Controlled Study
Acta Scientific Gastrointestinal Disorders
Irritable bowel syndrome (IBS) is a chronic and functional gastrointestinal dysfunction characterized by altered bowel movement and abdominal pain and has a complicated etiology. Probiotics are the novel therapy based on better understanding of the disease pathology. Patients and Methods: We conducted a control-placebo study, 157 subjects enrolled in this study, and followed up for 6 months, divided into three groups to compare the effect of probiotics and placebo on IBS patients. Results:doi:10.31080/asgis.2021.04.0230 fatcat:ucs4tty3dnfsbl7chicayfotpa